Items Tagged ‘targeted agent’

December 15th, 2015

Midostaurin Improves Survival in Subset of Acute Myeloid Leukemia

By

The targeted agent, midostaurin, has demonstrated a survival improvement among patients with acute myeloid leukemia (AML) that has the TMS-like tyrosine kinase 3 (FLT3) mutation. These results were presented at a plenary session at the 2015 annual meeting of the American Society of Hematology (ASH), in Orlando, Florida. Acute myeloid leukemia is a type of […]

View full entry

Tags: Acute Myeloid Leukemia, FLT3, Leukemia, midostaurin, myeloid leukemia, News, targeted agent


September 22nd, 2015

Gilotrif Improves Outcomes in Lung Cancer

By

The targeted agent Gilotrif (afatinib) improves outcomes compared to Tarceva (erlotinib) among patients with squamous cell lung cancer. These results were recently published in The Lancet Oncology. Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, NSCLC accounts for 75–80% of all lung cancers. Although progress has been made in […]

View full entry

Tags: afatinib, EGFR-positive, General Lung Cancer, gilotrif, Lung Cancer, News, squamous cell lung cancer, targeted agent